These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 21983314)

  • 1. Bromocriptine for diabetes mellitus type II.
    Valiquette G
    Cardiol Rev; 2011; 19(6):272-5. PubMed ID: 21983314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bromocriptine--unique formulation of a dopamine agonist for the treatment of type 2 diabetes.
    Scranton R; Cincotta A
    Expert Opin Pharmacother; 2010 Feb; 11(2):269-79. PubMed ID: 20030567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Why does quick-release bromocriptine decrease cardiac events?
    Bell DS
    Diabetes Obes Metab; 2011 Oct; 13(10):880-4. PubMed ID: 21569186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bromocriptine (Cycloset) for type 2 diabetes.
    Med Lett Drugs Ther; 2010 Dec; 52(1353-1354):97-8. PubMed ID: 21344781
    [No Abstract]   [Full Text] [Related]  

  • 5. [Bromocriptine].
    Matsuda M
    Nihon Rinsho; 2012 May; 70 Suppl 3():734-9. PubMed ID: 22768607
    [No Abstract]   [Full Text] [Related]  

  • 6. A new treatment option for type 2 diabetes.
    Belavic JM
    Nurse Pract; 2010 Jan; 35(1):51-2. PubMed ID: 20027023
    [No Abstract]   [Full Text] [Related]  

  • 7. Bromocriptine mesylate (Cycloset) for type 2 diabetes mellitus.
    Weiland CM; Hilaire ML
    Am Fam Physician; 2013 May; 87(10):718-20. PubMed ID: 23939451
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhaled human [rDNA origin] insulin, a novel formulation for diabetes mellitus.
    Pham DQ; Cohen H; Chu V
    J Clin Pharmacol; 2007 Jul; 47(7):890-903. PubMed ID: 17585117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mouse models of type II diabetes mellitus in drug discovery.
    Baribault H
    Methods Mol Biol; 2010; 602():135-55. PubMed ID: 20012397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adiponectin and its potential in the treatment of obesity, diabetes and insulin resistance.
    Haluzik M
    Curr Opin Investig Drugs; 2005 Oct; 6(10):988-93. PubMed ID: 16259219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promising new approaches.
    Reasner CA
    Diabetes Obes Metab; 1999 May; 1 Suppl 1():S41-8. PubMed ID: 11220287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bromocriptine: old drug, new formulation and new indication.
    Holt RI; Barnett AH; Bailey CJ
    Diabetes Obes Metab; 2010 Dec; 12(12):1048-57. PubMed ID: 20977575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Glucocorticoid-induced insulin resistance and diabetes mellitus. Receptor-, postreceptor mechanisms, local cortisol action, and new aspects of antidiabetic therapy].
    Meyer G; Badenhoop K
    Med Klin (Munich); 2003 Apr; 98(5):266-70. PubMed ID: 12721671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin U-500 in severe insulin resistance in type 2 diabetes mellitus.
    Crasto W; Jarvis J; Hackett E; Nayyar V; McNally PG; Davies MJ; Lawrence IG
    Postgrad Med J; 2009 Apr; 85(1002):219-22. PubMed ID: 19417173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Combination treatment with insulin and metformin in type 2 diabetes. Improves glycemic control and prevents weight gain].
    Hermann LS; Melander A
    Lakartidningen; 1999 Dec; 96(50):5616-9. PubMed ID: 10643226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Difference between biguanide and thiazolidinedione, and the significance of combination therapy of biguanide and thiazolidinedione].
    Masuda K; Terauchi Y
    Nihon Rinsho; 2010 May; 68(5):969-75. PubMed ID: 20446599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fate of the beta-cell in the pathophysiology of type 2 diabetes.
    Campbell RK
    J Am Pharm Assoc (2003); 2009; 49 Suppl 1():S10-5. PubMed ID: 19801360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Thiazolidindiones in type II diabetes mellitus].
    Bornkessel B
    Med Monatsschr Pharm; 1998 Mar; 21(3):66-8. PubMed ID: 9556974
    [No Abstract]   [Full Text] [Related]  

  • 19. Sitagliptin: a novel drug for the treatment of type 2 diabetes.
    Choy M; Lam S
    Cardiol Rev; 2007; 15(5):264-71. PubMed ID: 17700385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hypoglycemic treatment of type 2 diabetes].
    Thorsby P; Kilhovd B; Sletmo R; Martinsen S; Birkeland KI
    Tidsskr Nor Laegeforen; 2000 Aug; 120(20):2434-40. PubMed ID: 11475233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.